inspiring canadians to live better.

healthing leaf

inspiring canadians to live better.

healthing leaf
get healthing in your inbox with the morning checkup and weekender newsletter!
home / patient advocacy

opinion: provinces need to come together to make pharmacare a reality for all canadians

the october passage of canada’s historic pharmacare bill deserves celebration – but let’s save the real kudos for when pharmacare is a reality for canadians across the country.

by doug roth
published dec 20, 2024
read time 2 minute read
join the conversation
read time 2 minute read
join the conversation
with swift action, through the signing of provincial/federal bilateral agreements by spring 2025, it will be a reality for many millions of canadians. getty images
the october passage of canada’s historic pharmacare bill deserves celebration – but let’s save the real kudos for when pharmacare is a reality for canadians across the country. getting the bill through the house and the senate was one matter; the government must now get on with the work of finalizing bilateral agreements with provincial and territorial governments so that essential medications included in the bill will reach those who need them, swiftly.
canadians have been waiting long enough: the first phase of the pharmacare needs to be active by april 2025.
the pharmacare bill lays the foundational principles for the first phase of national universal pharmacare through publicly funded coverage of diabetes and contraceptive medications. this is a step in the right direction to improve drug access, affordability, coverage, equity and cost savings to our healthcare system.
pharmacare makes good health and financial sense. not just for diabetes and birth control – but for medications for heart disease and stroke too.
a feasible next step would include adding cardiovascular medications commonly used by people with diabetes, as diabetes is an important risk factor for heart disease and stroke. people with diabetes are more likely to develop heart disease at a younger age and three times more likely to die of it.

related stories

blood cancer treatment becomes first to benefit from canada's drug agency fast-track program
canada’s drug agency's time-limited recommendation program is set to deliver its first breakthrough with the blood cancer treatment epkinly.
when the wait time can be anywhere from 12 to 24 months, those living with grave diseases like cancer may not have that kind of time.

shaping the future of rare disease care in canada: new report outlines key considerations for fund allocation
a new report created by takeda pharmaceutical company highlights six key areas of unmet needs, offering an outline of how policymakers can go about making rare disease drug access and care better in canada.
ashley hickey lives with cvid, a rare disease, and knows all too well how important to rare disease strategy in the country is for herself and people like her.
story continues below
in 2016, 16 per cent of people in canada went without medication for heart disease, cholesterol and hypertension because they were too expensive, and the drug costs have only grown since the covid-19 pandemic. a 2024 poll commissioned by heart & stroke and the canadian cancer society found those who were diagnosed with a chronic health condition were significantly more likely to not have taken medication due to cost.
the same poll also found that these choices often caused health complication that needed emergency department (ed) visits, with almost one in 10 people in canada visiting the ed due to a worsening health issue because they were not able to afford their prescription medications.
the affordability barriers that prevent people from following their doctor’s instructions for their prescription drugs result in unnecessary hospitalizations, preventable deaths and increased costs to the health care system.
it doesn’t have to be this way.
the good news is that pharmacare is no longer just an idea, but approved legislation. with swift action, through the signing of provincial/federal bilateral agreements by spring 2025, it will be a reality for many millions of canadians.
story continues below
doug roth is the chief executive officer at heart & stroke.

comments

postmedia is committed to maintaining a lively but civil forum for discussion and encourage all readers to share their views on our articles. comments may take up to an hour for moderation before appearing on the site. we ask you to keep your comments relevant and respectful. we have enabled email notifications—you will now receive an email if you receive a reply to your comment, there is an update to a comment thread you follow or if a user you follow comments. visit our community guidelines for more information and details on how to adjust your email settings.

you may also like
asian family patient wait on line queue to receive medicine in hospital. attractive mother and daughter sit on chairs, waiting the pharmacy counter to provides services to patients in medical center.
opinion: how to help your child handle a visit to the emergency department
allen chankowsky
redefining cancer treatment: how one man strives to bring personalized care to all patients
profile picture of najeeb ashraf
living with type 1 diabetes: my journey through misconceptions, stigma and resilience
neda nasseri, product director of benefits at desjardins insurance and advisory board member with obesity matters; rachel atkins, board vice-chair, director of strategy, and patient advocate with obesity matters; and dr. david attalla, internal medicine and obesity medicine physician. (left to right)
the toll of obesity: long-term impact, access to care and insurance support
frustrated woman sits in a hospital corridor, the room is light and clean
blood cancer treatment becomes first to benefit from canada's drug agency fast-track program
you may also like
asian family patient wait on line queue to receive medicine in hospital. attractive mother and daughter sit on chairs, waiting the pharmacy counter to provides services to patients in medical center.
opinion: how to help your child handle a visit to the emergency department
allen chankowsky
redefining cancer treatment: how one man strives to bring personalized care to all patients
profile picture of najeeb ashraf
living with type 1 diabetes: my journey through misconceptions, stigma and resilience
neda nasseri, product director of benefits at desjardins insurance and advisory board member with obesity matters; rachel atkins, board vice-chair, director of strategy, and patient advocate with obesity matters; and dr. david attalla, internal medicine and obesity medicine physician. (left to right)
the toll of obesity: long-term impact, access to care and insurance support
you may also like
asian family patient wait on line queue to receive medicine in hospital. attractive mother and daughter sit on chairs, waiting the pharmacy counter to provides services to patients in medical center.
opinion: how to help your child handle a visit to the emergency department
allen chankowsky
redefining cancer treatment: how one man strives to bring personalized care to all patients